Lincoln Pharmaceuticals Q3 FY24 Results Live: Profit Rises by 29.74% YoY
Revenue Increased by 9.48% YoY & Profit Increased by 29.74% YoY10-02-2024
10-02-2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement with respect to un-audited financial results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2023.09-02-2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Advisory Letter Received From National Stock Exchange Of India Ltd ("NSE")
Advisory letter received from National Stock Exchange of India Ltd ("NSE").08-02-2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Financial Results Of The Company
Considered and approved un-audited financial results (standalone and consolidated) of the Company along with limited review reports for the Quarter and Nine Months ended on December 31, 2023.08-02-2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Board Meeting Outcome for OUTCOME OF THE BOARD MEETING
OUTCOME OF THE BOARD MEETING08-02-2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Board Meeting Intimation for Board Meeting Intimation For Inter-Alia To Consider And Approve The Un-Audited Financial Results For The Quarter And Nine-Months Ended On December 31, 2023.
LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 ,inter alia, to consider and approve the Un-Audited Financial Results for the Quarter And Nine-Months Ended On December 31, 2023 along with any other business, if any.25-01-2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Clarification On Volume/Price Movement Sought By BSE Limited
Clarification on Volume/Price Movement in the recent past.12-01-2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to provision of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate received from Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) for the Quarter ended December 31, 2023.08-01-2024
LINCOLN PHARMACEUTICALS LTD. - 531633 - Closure of Trading Window
Notice for closure of trading window.27-12-2023
LINCOLN PHARMACEUTICALS LTD. - 531633 - Intimation Of Placing Of The Matter Before The Board Of Directors W.R.T Identification Of Non-Compliance Of Regulation 17(1) Of SEBI (LODR) Regulations, 2015 (''Listing Regulations'') And Subsequent Action Taken By The Exchange In The Matter.
Intimation of Placing of the matter before the board of Directors w.r.t Identification of Non-Compliance of Regulation 17(1) of SEBI (Listing Obligations & Disclosure Requirement) Regulation, 2015 (''Listing Regulations'') And subsequent action taken by the exchange in this matter.03-11-2023